7 July 2020
Rigvir's new API (Active pharmaceutical ingredient) center of manufacturing has received GMP (Good Manufacturing Practice) compliance certification for the production of Rigvir virus ECHO-7. The project lasted for several years and cost a total of 2.5 million euros.
